Just months after MSD discontinued Lepto2, Virbac have released an alternative leptospirosis vaccine for dogs - Canixin® L. Canixin® L is an inactivated bacterial vaccine suspension specifically formulated to stimulate active immunity in dogs against two critical serogroups of Leptospira interrogans: Canicola and Icterohaemorrhagiae.
Licensed to reduce infection, clinical signs, kidney colonisation, renal lesions, and importantly, shedding in the urine, Canixin® L plays a crucial role in minimising the risk of the disease to both the individual and other animals that may come into contact. For the Canicola serogroup, Canixin® L offers the highest level of protection, including prevention of mortality.
The vaccine is licensed for use in dogs from 8 weeks of age, with a second injection administered 3 to 4 weeks later.
“We are pleased to be able to offer Canixin® L, allowing those using Canixin® DHPPi/L to vaccinate with L2 only in the intermediate years.”, said Rain Beckles – Product Manager. “It also provides an excellent opportunity for practices with clients specifically requesting an L2 vaccine.”
Interested vet practices should contact their Virbac Territory Manager.
